High-Caliber Femoral Dual-Lumen Cannula for ECCO2R in Hypercapnic Respiratory Failure: Efficacy and Safety Evaluation
Open Access
- 7 November 2025
- journal article
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 72 (3) , 255-262
Abstract
Extracorporeal carbon dioxide removal (ECCO₂R) prevents intubation and facilitates extubation in patients with hypercapnic respiratory failure. However, low-flow systems increase shear stress and need full anticoagulation, increasing the risk of circuit-related complications. We assessed the safety and efficacy of a high-caliber dual-lumen cannula, designed for jugular veno-venous extracorporeal membrane oxygenation (VV ECMO), repurposed for femoral vein insertion, with the aim of achieving higher blood-flow rates and more efficient CO₂ clearance. We retrospectively analyzed 16 intensive care unit (ICU) patients (62 years; 81% chronic obstructive pulmonary disease [COPD]) treated with ECCO₂R using a large-caliber dual-lumen cannula (20–23 Fr) inserted via the femoral vein. Key outcomes included changes in gas exchange, ventilatory support status, and complications. Extracorporeal carbon dioxide removal enabled rapid CO₂ clearance, with arterial carbon dioxide pressure (PaCO₂) decreasing from 68 [62–95] to 49 [45–56] mm Hg at 2 h, and pH increasing from 7.20 [7.16–7.27] to 7.36 [7.33–7.41]. Fifty-six percent of patients avoided intubation, whereas all intubated patients were extubated during ECCO₂R. The median support duration was 5 [4–7] days. No hemolysis was documented. One bleeding episode and one clotting event occurred; no thrombotic or cannulation-related complications were observed. Femoral vein cannulation with a large-caliber dual-lumen cannula for ECCO₂R appears feasible and safe. This strategy may offer technical and clinical advantages over conventional ECCO₂R systems, warranting prospective investigation.Keywords
This publication has 20 references indexed in Scilit:
- Physiology of extracorporeal CO2 removalIntensive Care Medicine, 2022
- Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory FailureJAMA, 2021
- Key Role of Respiratory Quotient to Reduce the Occurrence of Hypoxemia During Extracorporeal Gas Exchange: A Theoretical Analysis*Critical Care Medicine, 2020
- Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA studyIntensive Care Medicine, 2019
- Extracorporeal CO2 Removal: The Minimally Invasive Approach, Theory, and Practice*Critical Care Medicine, 2019
- The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case–control studyIntensive Care Medicine, 2016
- A Retrospective Observational Case Series of Low-Flow Venovenous Extracorporeal Carbon Dioxide Removal Use in Patients with Respiratory FailureASAIO Journal, 2016
- Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic reviewIntensive Care Medicine, 2015
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007